JASON BALLIN: Open Payments
NPI 1235293820 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$880 in 62 payments from 14 companies in 2025. Trend: 2023 $1,144 · 2024 $1,281 · 2025 $880
Food & beverage: $880
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $262 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Amgen Inc. | 4 | $80 |
| Janssen Biotech, Inc. | 4 | $70 |
| Mallinckrodt Hospital Products Inc. | 2 | $55 |
| LEO Pharma Inc. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| GENZYME CORPORATION | 2 | $48 |
| Galderma Laboratories, L.P. | 2 | $33 |
| UCB, Inc. | 1 | $26 |
Products named: SKYRIZI, COSENTYX, OTEZLA, TREMFYA, ACTHAR, RINVOQ, Sotyktu, DUPIXENT.
Industry payments across OH — which companies pay providers there.
